Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-001612-62Phase 3Completed
Phase 3 trial of Human Diploid Cell Rabies Vaccine in rabies (2 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Primary: boostability of rabies antibodies on day 7 after booster vaccination. Started Aug 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-001612-62.